Clients value Greg’s strategic counsel relating to the protection of their intellectual property assets in the U.S. and abroad. Greg works extensively with universities and companies in the life sciences, pharmaceutical, healthcare and chemical industries. His outstanding track record is built on successful outcomes in high-profile and high-value life sciences and chemical patent matters.
Greg is recognized as a top lawyer by Chambers USA which states: “Gregory Hartwig stands out for his experience assisting higher education facilities with pharmaceutical patent prosecutions. He is also adept at conducting IP due diligence on significant commercial transactions. Clients say Greg is ‘a top-notch chemical and life science attorney who is commercially very astute’ and that ‘Greg's instructions are always on point and he's very experienced.’"
Greg’s extensive background encompasses patent preparation and prosecution, enforcement, and technology dispute resolution, as well as licensing and opinion work in the following technical areas:
- Drug discovery (small molecule) and pharmaceutical formulations
- Diagnostics
- Specialty chemicals and polymers
- Material science
- Medical devices
Greg is a leader in Michael Best’s Higher Education Industry Group. He chairs the firm's University Patent and Technology Commercialization Practice, which provides a variety of features designed to develop close, value-added working relationships with university professionals and faculty.
Greg is a persuasive and effective advocate for universities across the U.S., and brings in-depth knowledge of academic-corporate partnerships, as well as extensive experience training and educating university professionals and faculty.
Universities and emerging businesses view him as a partner in commercializing their technologies. Greg works closely with our Venture Best team and our Healthcare Innovation Group to help bring products to the market.